Welcome to CSNpharm! For Research Use Only!
Angiotensin Receptor
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN25363 | ZD 7155(hydrochloride) | 146709-78-6 | ZD 7155 hydrochloride is selective competitive antagonist of the angiotensin II type 1 (AT1) receptor. |
| CSN12536 | Valsartan | 137862-53-4 | Valsartan is a selective angiotensin II AT1 receptor antagonist with elimination half-life of 6 hours |
| CSN16012 | trans-Tranilast | 70806-55-2 | trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis. |
| CSN17430 | Tranilast sodium | 104931-56-8 | Tranilast is an antiallergic agent. |
| CSN12122 | Tranilast | 53902-12-8 | Tranilast can antagonize angiotensin II and also work as an antiallergic agent. |
| CSN12552 | Telmisartan | 144701-48-4 | Telmisartan is an angiotensin II receptor antagonist with Ki value of 37nM used in the management of hypertension with elimination half-life of 24 hours |
| CSN12037 | Tasosartan | 145733-36-4 | Tasosartan is a long-acting angiotensin II receptor blocker |
| CSN16875 | PD 123319 ditrifluoroacetate | 136676-91-0 | PD123319 Ditrifluoroacetate is a potent selective and non-peptide angiotensin AT2 receptor antagonist |
| CSN11662 | PD 123319 | 130663-39-7 | PD 123319 is a potent selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM |
| CSN12551 | Olmesartan medoxomil | 144689-63-4 | Olmesartan Medoxomil is a synthetic imidazole-derived angiotensin II receptor antagonist acting as a prodrug with an antihypertensive property |
| CSN11603 | Olmesartan | 144689-24-7 | Olmesartan is an antagonist of angiotensin II receptor, working as an antihypertensive agent. |
| CSN12515 | Losartan potassium | 124750-99-8 | Losartan Potassium is the potassium salt form of Losartan, which is a compeitive AT1 receptor inhibitor with IC50 value of 20 nM. |
| CSN11333 | Losartan | 114798-26-4 | Losartan is a compeitive AT1 receptor inhibitor with IC50 value of 20 nM |
| CSN22035 | L-159282 | 157263-00-8 | L-159282 is a highly potent, orally active, nonpeptide angiotensin II receptor antagonist, with anti-hypertensive activity. |
| CSN12537 | Irbesartan | 138402-11-6 | Irbesartan is a selective and competitive nonpeptide angiotensin II antagonist with antihypertensive activity. |
| CSN13567 | Fimasartan | 247257-48-3 | Fimasartan is an improved non-peptide angiotensin II receptor blocker used for the treatment of hypertension and heart failure which enables higher potency and longer duration than losartan |
| CSN24625 | Losartan Carboxylic Acid | 124750-92-1 | EXP 3174 is a selective and noncompetitive antagonist of AT1 receptor with IC50 of 37 nM. |
| CSN10923 | Eprosartan mesylate | 144143-96-4 | Eprosartan Mesylate is a reversible and competitive angiotensin II receptor inhibitor |
| CSN10922 | Eprosartan | 133040-01-4 | Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure |
| CSN18823 | Olodanrigan | 1316755-16-4 | EMA401 a highly selective AT2R antagonist inhibition of augmented AngIIAT2R induced p38 and p42p44 MAPK activation and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons |
| CSN21624 | 1-((Ethoxycarbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazole-5-carboxylate | 149968-26-3 | Elisartan is a selective nonpeptide angiotensin II (AT1) antagonist. |
| CSN12544 | Candesartan | 139481-59-7 | Candesartan is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 026 nM |
| CSN12553 | Candesartan Cilexetil | 145040-37-5 | Candesartan Cilexetil is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 026 nM |
| CSN12705 | Azilsartan medoxomil | 863031-21-4 | Azilsartan Medoxomil is an orally available angiotensin II type 1 AT1 receptor antagonist with IC50 value of 26 nM |
| CSN13633 | Azilsartan medoxomil monopotassium | 863031-24-7 | Azilsartan medoxomil is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension. |
| CSN10369 | Azilsartan | 147403-03-0 | Azilsartan is an orally available angiotensin II type 1 AT1 receptor antagonist with IC50 value of 26 nM |
| CSN10369 | Azilsartan | 147403-03-0 | Azilsartan is an orally available angiotensin II type 1 AT1 receptor antagonist with IC50 value of 26 nM |
| CSN16922 | AVE 0991 sodium salt | 306288-04-0 | AVE 0991 sodium is a nonpeptide Ang-1-7 receptor Mas agonist represents an important step for exploration of the effects of Ang-1-7 and testing of its potential as a cardiovascular drug |
| CSN16917 | AVE 0991 | 304462-19-9 | AVE 0991 is a nonpeptide Ang-1-7 receptor Mas agonist |
| CSN20314 | AT2 receptor agonist C21 | 477775-14-7 | AT2R agonist C21 is a small-molecule ATR receptor (AT2R) agonist. |
| CSN13483 | Sacubitril | 149709-62-6 | AHU-377 and valsartan can compose LCZ696 in a 11 molar ratio It also works as an inhibitor of neprilysin with IC50 value of 5 nM |
| CSN22012 | A81988 | 141887-34-5 | A81988 is a potent, competitive, non-peptidic antagonist of angiotensin AT1 receptors. |
| CSN21995 | (2S,4S)-Sacubitril | 149709-63-7 | 2S,4S-Sacubitril is the impurity of Sacubitril and Sacubitril is approved by the Food and Drug Administration for use in combination with valsartan for the treatment of patients with heart failure. |
| CSN21996 | 2R,4S-Sacubitril | 761373-05-1 | 2R,4S-Sacubitril is the impurity of Sacubitril and Sacubitril is approved by the Food and Drug Administration for use in combination with valsartan for the treatment of patients with heart failure. |
| CSN28996 | Sparsentan | 254740-64-2 |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
